title: A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations.
abstract: The association of familial Mediterranean fever (FMF) and polyarteritis nodosa (PAN) has been well established. These patients have been reported to have an overall better prognosis than other PAN patients. Herein we report a patient with FMF and PAN who died of sepsis following a severe course of recurrent bleeding episodes which required multiple embolization attempts. The 39-year-old Turkish male presented with abdominal pain of 1-month duration. He had been diagnosed with FMF at the age of 24. On admission, he had pallor with general ill appearance. Rebound tenderness was obtained in the right upper abdominal quadrant. He had mild anemia, leukocytosis, thrombocytosis, and hypoalbuminemia. On the 2nd day of his admission, he developed hypotension with a rapid decline in hemoglobin level. Abdominal angiography showed multiple aneurysms in the branches of renal arteries, superior mesenteric artery, and hepatic arterial system including left renal infarct, suggesting PAN. He was put on high-dose steroids and oral cyclophosphamide. Despite medical treatment, he developed intense abdominal pain, hypotension, tachycardia, and a rapid fall in hemoglobin on four occasions. Active bleeding sites were embolized in two different angiography sessions. Although the patient experienced no more recurrent bleeding, he died of multiorgan dysfunction syndrome resulting from sepsis 6 weeks after admission. Polyarteritis nodosa associated with FMF may follow a grave course despite immunosuppressive therapy. Arterial embolization should be considered in the presence of bleeding aneurysms in addition to immunosuppressive therapy.
authors.affiliation: Division of Immunology-Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey. servet.akar@deu.edu.tr
authors.forename: Servet
authors.initials: S
authors.lastname: Akar
authors.forename: Yigit
authors.initials: Y
authors.lastname: Goktay
authors.forename: Baris
authors.initials: B
authors.lastname: Akinci
authors.forename: Dilek
authors.initials: D
authors.lastname: Tekis
authors.forename: Kadir
authors.initials: K
authors.lastname: Biberoglu
authors.forename: Merih
authors.initials: M
authors.lastname: Birlik
authors.forename: Fatos
authors.initials: F
authors.lastname: Onen
authors.forename: Mehmet
authors.initials: M
authors.lastname: Tunca
authors.forename: Nurullah
authors.initials: N
authors.lastname: Akkoc
mesh_terms: D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004621:Embolization, Therapeutic / Q000379:methods; D010505:Familial Mediterranean Fever / Q000150:complications / Q000473:pathology* / Q000628:therapy; D017809:Fatal Outcome; D006470:Hemorrhage / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D008107:Liver Diseases / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D010488:Polyarteritis Nodosa / Q000150:complications / Q000473:pathology* / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D003520:Cyclophosphamide; D011239:Prednisolone; D008775:Methylprednisolone